🧯 A Lame-Duck Freeze, A Reshaped Retail Launch, And A Hemp Bill That Tests Federalism

Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.

Today's edition is sponsored by Norton Neo and The Hybrid podcast, with latest guest Willy Vlasic of Vlasic Labs. Their support keeps these briefings free and focused on what actually matters.

A Massachusetts commission facing dissolution imposed a market intervention on its way out. A Virginia governor reshaped a retail launch around delay and steeper penalties after consulting governors she will not name. A North Carolina advisory council concluded that THC should be regulated by molecule, not plant. A Rhode Island equity rollout stalled again in court. The question running underneath each of these is the same: what happens when the authority to govern a market is exercised in its final hours, or before it is fully built, or against the people it was meant to lift.

🧯 Lame-duck cultivation freeze
🌿 Molecule-based cannabis regulation
🏛️ A hemp bill meets state sovereignty

The Cannabis Control Commission voted 3-1 Thursday to freeze new cultivation licenses starting June 16th, a 120-day moratorium imposed days before the commission itself is scheduled to be dissolved. Governor Maura Healey has until April 19th to sign legislation that terminates the current five-member commission and reconstitutes it at three members of her choosing. Commissioner Bruce Stebbins, who voted against the freeze, told reporters he wanted a clearer data standard for whether future commissioners should extend the pause. Flower prices have collapsed from $401.43 an ounce in December 2020 to $113.68 this past December, with 31 licensees in court-appointed receivership against 186 cultivator and micro-business licenses and more than 4.2 million square feet of maximum canopy. Supply discipline may be the right call. A lame-duck body imposing a moratorium by vote, without a public comment period and without a documented evidentiary basis grounded in a market study, hands the incoming commission a procedural problem that a good administrative law attorney is already sketching. Social equity applicants who secured grants for cultivation licenses they now cannot obtain are exactly the plaintiffs most likely to test it. Plenty of researchers exist who can help states assess supply, demand, and equity dynamics. A vote on a Thursday afternoon is not a substitute for that work. (State House News Service; Boston Globe)

💵 Cannabis prices get cited as a market health indicator, but a national price signal is an incomplete read in an industry without a national market. Every state builds its own supply chain against its own property costs, tax structure, license caps, and cultivation environment. What looks like price discipline in one market can be glut in another and artificial scarcity in a third. Price matters as a data point. It is not the verdict people sometimes treat it as. (Weedmaps)

Governor Josh Stein is backing adult-use legalization after his State Advisory Council on Cannabis concluded this month that North Carolina's existing market is neither meaningful prohibition nor meaningful regulation. The council went further than the governor on one consequential point. Rather than construct separate frameworks for hemp and marijuana, the interim report recommends regulating THC as a molecule regardless of plant source, arguing "the plant source is irrelevant and should not drive different treatment when the intoxicating compound is the same." The state's unregulated intoxicating market is estimated at $3.2 billion annually. The Republican-led General Assembly reconvenes April 21st and has declined to move even medical legalization in recent sessions, so the political ceiling here is low. The analytical ceiling is higher. Molecule-based regulation is the framework most states have been unable or unwilling to adopt even as the hemp-marijuana distinction has degraded into a fiction on store shelves. North Carolina is the rare state where an advisory body assembled by the governor said the quiet part out loud and put it in writing. (Carolina Journal)

🏈 The NCAA is quietly moving away from automatic stigma on cannabis and toward something closer to health and education policy. Institutions do not shift on this kind of question without underlying pressure, and the pressure here is the contrast with professional leagues that have already adjusted. Charlie Baker, the association's president and a former Massachusetts governor I worked with during the state's adult-use rollout, is not a plant enthusiast. Movement under his watch tells you where college athletics sits culturally in 2026. (Harvard Independent; NCAA)

Senator Rand Paul is preparing legislation he says would return hemp regulatory authority to the states, a counterpunch to the federal intoxicating hemp ban that takes effect in November. Paul, Senator Amy Klobuchar, and Senator Jeff Merkley already filed S.2112 earlier this year to delay the ban's effective date by two years. Paul's new bill would go further, letting states set their own standards even where those standards differ from the new federal limits. Paul does not have many natural allies in the Senate on this or on most other issues, and his emergency amendment to strip the hemp language from the November appropriations package was tabled 76 to 23. The sovereignty argument is where this gets interesting. States have built real regulatory infrastructure around hemp across a spectrum that runs from bans to full allowance, complete with licensing, testing protocols, tax compliance, and interstate commerce rules. Federal preemption erases years of state-level policymaking. Paul may not be the ideal messenger, but the argument he is carrying deserves a clearer hearing than the Senate floor gave him last fall. (Marijuana Moment)

🧾 New Jersey's hemp crackdown is forcing a public distinction most consumers never had to make. Intoxicating hemp introduced a huge new population to THC through liquor stores, gas stations, and convenience retail, and the destigmatization that came with that expansion is not nothing. What matters more is that a consumer walking into a traditional commerce lane expects a product that has been tested, accurately labeled, and manufactured under safety standards they do not have to verify themselves. That expectation is the bar New Jersey is now enforcing. (NorthJersey.com)

Governor Abigail Spanberger said the amendments she sent back to the General Assembly on April 13th were shaped by conversations with governors in other legalized states, but she has not named which ones. Her changes push adult-use retail sales from January 2027 to July 2027, cut retail licenses from 350 to 200, raise the excise tax from 6 percent to 8 percent starting in 2029, reduce the possession limit from 2.5 ounces to 2, and introduce new criminal penalties including a Class 2 felony for transporting 50 pounds or more across state lines. Bill sponsors Senator Lashrecse Aird and Delegate Paul Krizek pushed back, with Aird calling the governor's substitute a "significant departure" and Krizek warning it "creates a less accessible legal marketplace." Senate Majority Leader Scott Surovell noted that amendments of this magnitude are usually communicated during the legislative process rather than after. Methodical rollout is a reasonable goal. Building a market around another state's experience gets harder when Virginia sits directly between Maryland and the District of Columbia, with revenue forecasts and business timelines already priced against the original launch date. The General Assembly reconvenes April 22nd to consider the amendments. (Marijuana Moment)

Connecticut is weighing a shift from its potency-based cannabis excise tax to a flat rate, a change that could lower retail prices by as much as 11 percent according to Fine Fettle CEO Ben Zachs. The move is a direct response to Massachusetts, where lawmakers recently raised the single-transaction purchase limit and where Representative David Rutigliano is calling the dynamic a cannabis "arms race." Connecticut sales slipped from $293 million to $290 million between 2024 and 2025 despite nearly a million more transactions, a signal that consumers are crossing state lines. Border economics works in both directions. In Indiana, police arrested a Chicago resident after a traffic stop revealed he had bought 241 grams of cannabis legally at a Michigan dispensary; he was charged with a felony. Ohio's SB 56, passed late last year, criminalizes cannabis purchased out of state even as Ohio's own adult-use market operates under a license cap that keeps prices well above Michigan's. A Fox-8 analysis found an Ohio consumer could save nearly $80 driving to Michigan to buy, fuel included. The legal arbitrage that built the regional cannabis economy has always depended on light enforcement at the state line. Indiana and Ohio are showing operators what the other version of that bet looks like. (Connecticut Insider; Fox-8)

📱 The case that cannabis brands are still marketing to a version of the internet that has already moved on is harder than it looks. Operators live inside real platform restrictions - Instagram takedowns, Google ad bans, TikTok enforcement that can erase an account overnight - and those restrictions push brands toward the coded and the clever while alcohol and sports betting get the in-your-face lane. Creative under constraint drifts into cute, and cute does not convert. Canna Connect's founders argue X has become the home of cannabis culture precisely because it permits what other platforms forbid, and one of their campaigns turned an iPhone video and a threaded product link into 25 million impressions. The deeper issue is that the advertising environment has been fragmented and restricted for so long that the industry has not yet produced the body of work it needs to know what its best marketing actually looks like. (High Times)

Rhode Island sold legalization as an ownership project that would include worker cooperatives and social-equity retail, and nearly four years in, none of those new stores is open. The current lottery is frozen again because of a court fight over the state's residency rule. The litigation is real and the procedural tangle is real, but neither fully explains why an equity rollout launched in 2022 has so little to show. Applicants have spent years on rent, legal fees, and application costs for a market they cannot enter, while incumbent operators continue to serve consumers without the competitive pressure the equity program was supposed to create. Equity commitments lose value when the state cannot execute them. The incumbents notice that. So does the next cohort of applicants now deciding whether to file at all. (The Boston Globe)

🧪 President Trump is reportedly weighing an executive order on ibogaine, a move that would sit inside a broader administration posture toward veterans, trauma care, and substances long treated as untouchable. Ibogaine is not cannabis. It is not psilocybin. It is a compound with real therapeutic value for PTSD, addiction, and certain mood disorders, and a cardiotoxicity profile that has killed people. Lumping every Schedule I substance into one liberalization conversation is how public policy gets made badly. Cannabis advocates have spent years arguing their plant deserves to be treated on its own terms. That argument works in both directions. (Marijuana Moment)

Senator Dan Laughlin, one of the most visible Republican legalization supporters in Harrisburg, has now said publicly what has been obvious for a while. Senate Republicans do not want to take a politically costly cannabis vote unless the House goes first and demonstrates that a bill can actually reach the governor's desk. That is not a drafting problem, a coalition problem, or a substance problem. It is pure electoral math inside a divided legislature, sharpened by the political reality that Governor Josh Shapiro is a likely 2028 presidential contender and Republican legislators are not in the business of handing him a signature win. Cannabis as policy is one conversation. Cannabis as politics is the conversation actually happening in Harrisburg. The operators, advocates, and policymakers trying to move this forward are navigating both. Anyone who has lived that dynamic recognizes it on sight. (Cannabis Business Times)

The Nebraska Medical Cannabis Commission approved the last of four cultivator licenses this week, with one grower asking for a variance so it can be harvest-ready by October 1st rather than push planting to 2027. That is movement. It is not yet a program. Manufacturer applications still have no timeline. No Nebraska physician can recommend medical cannabis without risking their license, because the legislature defeated a protection bill earlier this year. Advocate Crista Eggers of Nebraskans for Medical Marijuana called that defeat "one of the most disgraceful displays" she had seen in the Legislature. Sequencing a rollout to start with cultivation and work downstream is a defensible strategy. Sequencing will not matter if the political scaffolding underneath it keeps collapsing. A crop in the ground is not the same thing as patients with access to it. (MJBizDaily)

📅 For those tracking Latin American cannabis policy, Rudick Law Group is hosting a webinar titled "Colombia: Supporting and Amplifying Local Economies in Cannabis, Wellness and Tourism" on April 30th at 1:00PM Eastern. Colombian attorney Juliana Salazar will cover where real opportunity exists for foreign entrants, the common pitfalls, and what community-centered business practice actually looks like on the ground. (Rudick Law Group)

Missouri's Department of Health and Senior Services filed proposed rules on April 3rd to establish licensed cannabis research facilities, with a public comment period opening next month. Voters authorized the research category in 2022, and the state is only now moving rules needed to make it real. The four-year gap tells you something about how rulemaking tends to sequence across a cannabis program, with commerce moving first and research trailing. Missouri's positioning matters most in the context of probable federal rescheduling, which will open the research pipeline in ways that favor states with infrastructure already in place. Massachusetts has the structural advantage given Harvard, MIT, and the teaching hospital network. Missouri making an early move is the kind of thing that looks small now and consequential in five years. Governance is slower than commerce, and that is usually a feature. (Missouri Independent)

Los Angeles is back in court against an alleged operator of multiple unlicensed cannabis shops. The city's larger problem is visible enforcement against an illicit market that compliant operators have spent years arguing is eating their lunch, compounded by hundreds of millions in unpaid cannabis taxes on the licensed side. Enforcement and cultural memory do not separate cleanly in this industry. The history of cannabis policing in this country is recent enough that the scars are still live, and the communities bearing those scars are the same communities that bore the original enforcement. City Hall has to hold the market integrity argument and that history simultaneously. A single lawsuit does not do that work. It is a start, not an answer. (Law360)